Geneva, Sept. 23 -- International Clinical Trials Registry received information related to the study (ISRCTN84894190) titled 'Immune imbalance in pediatric persistent immune thrombocytopenia' on Sept. 11.
Study Type: Observational
Study Design:
Prospective cohort study (Treatment)
Primary Sponsor: First Affiliated Hospital of Xinxiang Medical University
Condition:
Immune thrombocytopenia (ITP)
Haematological Disorders
Intervention:
34 children with primary persistent ITP were enrolled in the ITP group, whereas 30 age- and sex-matched healthy children undergoing physical examinations during the same period served as control group.
The treatment protocol for the ITP group was as follows. Based on the Chinese Guidelines for the Dia...